| Financial Year |
March 31 2023 |
| Monetary Funds |
1,474,611,133.66 |
| Held-for-trading Financial Assets |
32,193,278.56 |
| Notes Receivable |
6,332,635.24 |
| Accounts Receivable |
1,170,213,828.03 |
| Advances to Suppliers |
137,073,461.40 |
| Other Receivables |
54,212,012.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
168,367,851.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
50,180,144.64 |
| Other Current Assets |
42,526,658.50 |
| Total Current Assets |
3,184,421,418.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
312,725,633.99 |
| Long-term Equity Investment |
16,449,691.57 |
| Investment Properties |
-- |
| Fixed Assetes |
340,551,278.13 |
| Under-construction Projects |
2,026,528.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
210,877,872.21 |
| R&D expenses |
6,441,522.56 |
| Goodwill |
586,686,813.72 |
| Long-Term Deferred and Prepaid Expenses |
10,215.59 |
| Deferred Income Tax Assets |
130,212,828.93 |
| Other Non-Current Assets |
16,377,425.41 |
| Sub-Total of Non-Current Assets |
1,659,216,021.15 |
| Total Assets |
4,843,637,439.41 |
| Short-Term Loans |
151,692,014.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
32,841,428.00 |
| Accounts Payable |
308,944,721.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,409,588.21 |
| Taxes Payable |
179,295,600.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
99,863,946.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,892,761.32 |
| Other Current Liabilities |
2,971,996.58 |
| Sub-Total of Current Liabilities |
821,394,136.33 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
380,169.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,509,371.41 |
| Total Liabilities |
833,903,507.74 |
| Paid-In Capital(Or Share Stock) |
504,500,508.00 |
| Capital Surplus |
2,488,884,852.39 |
| Surplus Reserve |
68,988,429.48 |
| LESS:Treasury Stock |
60,441,924.53 |
| Undistributed Profits |
979,744,068.41 |
| Minority Stockholder's Interest |
28,057,997.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,981,675,933.75 |
| Owner's Equity（Stockholder's Equity） |
4,009,733,931.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,843,637,439.41 |
